Metab/Obesity2 Flashcards

1
Q

Is the process of biochemical reactions occuring in the body’s cells that are necessary to produce energy, repair cells and maintain life.
-through the release of hormones, such as insulin, the endocrine system controls the cellular activity that regulates growth and body metabolism.

A
  1. Concepts of Metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

a disorder of hyperglycemia resulting from defects in insulin secretion, insulin action, or both, leading to abnormalities in carbohydrate, protein and fat metabolism.
Type 1
Type 2

A
  1. Concepts of Metabolism (DM)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Destruction of beta cells, usually leading to absolute deficiency of insulin.

A
  1. Concepts of Metabolism

Type 1 Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A range from predominantly insulin resistance with relative insulin deficiency to predominantly secretory defect with insulin resistance

A
  1. Concepts of Metabolism

Type 2 Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Storage of excess calorie fats, resulting from excess energy intake, decreased energy expenditure, or a combo of both. Several hormones are involved in regulating obesity, including thyroid hormone, insulin and leptin. Genetic play a role as well

A

1 Concepts of Metabolism

Obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

**Genetics; Type 1 DM
**Type 2 DM; Hx of diabetic parents or siblings
(child 15% chance of developing, 30% developing glucose intolerance)[inability to metabolize carbs normally]
**Obesity; which is 20% over the desired body weight or BMI at least 27 kg/m2.
-Peripheral insulin resistance~decrease the # of available insulin receptor sites in cells of skeletal muscles and adipose tissues.
-obesity also impairs the ability of the beta cells to release insulin in response to increasing glucose levels.
**Physical inactivty
**Race/Ethnicity
**Women-hx of gestational diabetes, polycystic ovary syndrome; or delivering more than 9 lb. baby
**HTN; more than 130/85, decrease HDL, cholesterol levels more than 35 mg/dl and/or triglycerides more than 250 mg/dl
**Metabolic Syndrome; HTN, abd. obesity, dyslipidemia, increase in C-reactive protein, and a fasting blood glucose greater than 100 mg/dl, increase risk of DM2, coronary HD, and Stroke

A

2.Risk Factors r/t DM & Obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

prescription for weight loss and increased activity levels

A

Treatment/preventative measures for DM & Obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Type 2: Condition of fasting hyperglycemia that occurs despite the availability of endogenous insulin (produced by ones own body) despite amount produced; available its functioning is impaired by insulin resistance.
-Insulin resistance exceeds the ability of the pancreas to compensate, overtime the pancreas fails to produce enough insulin to meet body needs.
-there is enough to break down fats with resultant ketosis; (an accumulation of ketone bodies produced during oxidation of fatty acids)
(Thus making Type 2; nonketotic form of diabetes)

A
  1. Pathophysiology of obesity and DM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  • Hx in family
  • obesity; BMI more than 27 kg/m2 or greater~peripheral insulin resistance
  • physical inactivity
  • race/ethnicity
  • women, hx of gestational diabetes, big babies more than 9 lbs.
  • HTN; more than 130/85 mmHg, decrease HDL, increase cholesterol, and triglycerides more than 250 mg/dL
  • Metabolic Syndrome; a disorder characterized by the presence of 3 or more of the following: increase waist circumference, HTN, increase blood triglycerides, and fasting blood sugar, low HDL, cholesterol more than 35 mg/dL
A
  1. Risk Factors of DM2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A disorder of hyperglycemia resulting from defects in insulin secretion, insulin action, or both, leading to abnormalities in carbohydrate, protein, and fat metabolism.

A
  1. Diabetes Mellitus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Slow onset, often unaware of the disease until healthcare is sought for other issue.
-Hyperglycemia increase gradually
-1/2 of diagnosed (newly) already have complications. (DM2)
-DM2 hyperglycemia not as severe as DM1, but similar symptoms. ie. polyuria and polydipsia, blurred vision, fatigue, paresthesias, and skin infections.
-If available, insulin decrease in times of stress (physical or emotional) may develop diabetic ketoacidosis; but uncommon.
~Hypoglycemic meds begun when lifestyle changes are insufficient.
-usually a combo of insulin and hypoglycemic meds used to achieve best glycemic control.

A
  1. Manifestations of DM2 & Obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
Alterations in blood glucose levels
Alterations in cardiovascular system
Neuropathies
Increase susceptibility to infection
Periodontal disease
A

4. Complications of Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
Hyperglycemia and hypoglycemia,
diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS),
A

4 Acute complications of Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

increase glucose levels

A

hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

a form of metabolic acidosis that develops when there is an absolute deficiency of insulin and an increase in the insulin counterregulatory hormones. It may also be induced by stress in an indiv. with type 1 DM

A

DKA Diabetic Ketoacidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Blood glucose between 4 & 8 am. Not a response to hypoglycemia (type 1 and type 2). [teenagers; growth hormone] decrease peripheral uptake of glucose.

A
#4. Complications of Diabetes
Dawn Phenomenon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Combo of hypoglycemia during the night with a rebound morning rise in blood glucose to hyperglycemic levels. (counterregulatory hormones stimulated)
*gluconeogenesis & glycogenolysis inhibits peripheral glucose use: insulin resistance for 12-48 hrs.

A
#4. Complications of Diabetes
Somogyi Phenomenon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Untreated type1 DM continues, the insulin deficit causes fat stores to break down; the result is continued hyperglycemia and mobilization of fatty acids with a subsequent ketosis

A

Diabetic Ketoacidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

When an individual is sick, who has an infection or decreases or omits insulin doses is @ greater risk of

A

DKA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
  1. HYperosmolarity from hyperglycemia and dehydration
  2. Metabolic acidosis is from an accumulation of ketoacids
  3. Extracellular volume depletion from osmotic diuresis
  4. Electrolyte imbalances (loss of K and Na) from osmotic diuresis.
A

Diabetic Ketoacidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Severe dehydration and acidosis & DKA need immediate medical attention
-blood glucose levels greater than 250 mg/dL, decrease in pH, and ketone in urine.

A

Manifestations of DKA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Regular insulin is used in the treatment of DKA
-mild ketosis; sub q insulin
-severe ketosis; iv insulin
Regular insulin only insulin giving IV!

A

Treatment of DKA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Occurs in individuals who have type 2 DM and is characterized by a plasma osmolarity of 340 mOsm/L or greater (normal range 280-300 mOsm/L. Increase blood glucose levels and altered LOC

Onset is slow; 24 hrs to 2 weeks
Life-threatening medical emergency;
**precipitating factors; infection, therapeutic agents, therapeutic procedures, acute illness and chronic illness
**MOST common; infection

A

Hyperosmolar Hyperglycemic State HHS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Treatment is correcting fluid and electrolyte imbalances, decrease blood glucose levels and give insulin.

A

Treatment of HHS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

decrease blood glucose levels; common in ind. with type 1 DM, occasionally DM2

A

Hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Insulin Shock; insulin reaction “the lows” in type 1 DM
;results primarily from a mismatch between insulin intake (error of insulin dose), physical activity, and carb availability (omitting a meal)
-intake of alcohol and drugs, such as
-chloramphenicol (Chloromycetin)
-sodium warfarin (Coumadin)
-monoamine oxidase inhibitors
-probenecid (Benemid)
-Salicylates
-Sulfonamides; all can cause hypoglycemia

A

Hypoglycemia causes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Compensatory ANS response:
-impaired cerebral function; decrease glucose availability to brain
-onset SUDDEN, and blood glucose decrease of 45-60 mg/dL
**Severe hypoglycemia may cause death
Hypoglycemia Awareness; counterregulatory system stops working

15/15 Rule! 15 g. of rapid acting sugar; Apple juice. 1 tsp honey, Wait 15 mins, monitor blood glucose again, then if still low eat another 15 g. of carbs.

A

Manifestations Hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Alterations in cardiovascular system

  • the peripheral & ANS
  • mood as well as increase susceptibility to infection
  • periodontal disease
  • complication involving the feet
A

Chronic Complications of DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q
Changes in lg blood vessels resulting in atherosclerosis
Abnormalities in platelets
RBC's
clotting factors
Changes in arterial walls
A

Chronic Complications

Cardiovascular System changes with DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

major risk factor for developing of an MI.

***MOST common cause of death in an indiv with DM

A

Chronic Complications

Coronary Artery Disease with DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

more than 140/80 mmHg common comorbidity of DM. Affects 20-60% with diabetes
Complications;
-retinopathy
-nephropathy
-HTN; reduced by weight loss, exercise, and decrease in Na intake and alcohol comsumption.
-plus meds to lower

A

Chronic Complications

HTN with Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

with diabetes 2-6x more likely to have a stroke.
HTN; risk factor
~atherosclerosis of cerebral vessels develop @ an earlier age and is more extensive with ind. with diabetes.
Manifestations of impaired cerebral circulation are similar-hypoglycemia or HHS, blurred vision, slurred speech, weakness, and dizziness.

A

Chronic Complications

Stroke with Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

lower extremities accompany both types of diabetes, but greater in ind. with type 2 DM.

A

Chronic Complications

Peripheral Vascular Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

refers to the changes in the retina that occur in the ind. with diabetes.

  • retinal capillary structure undergoes alterations in blood flow, then retinal ischemia and breakdown in the blood; retinal barrier.
  • *Leading cause of blindness in individuals between 20 & 74 years of age.
  • Stage I: nonproliferative retinopathy; dilated veins, microaneuryms, edema of the macula; exudates
  • Stage II; Retinal ischemia infarcts of nerve fibers “cotton wool”
  • Stage III; proliferative retinopathy; traction on the vitreous humor, may cause hemorrhage or retinal detachment.
A

Chronic complications DM

Diabetic Retinopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

disease of the kidneys characterized by the presence of albumin in the urine, HTN, edema, and progressive renal insufficiency.

  • occurs in 20-40%
  • **Single leading cause of end-stage renal disease.

1st indication of nephropathy is microalbuminuria; (a low but abnormal level of albumin in the urine)
*****Aggressive antihypertensive management!!
B/c HTN accelerates the progress of diabetic nephropathy.

Glomerulosclerosis thickens the basement membrane and simultaneously makes it functionally leaky, allowing large molecules (ie. protein) to be lost in the urine.

A

Chronic complications

Diabetic Nephropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

fibrosis of the glomerular tissue

A

Glomerulosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Peripheral and Visceral neuropathies are disorders of the peripheral nerves and the ANS.
-Ind with diabetes, these disorders are manifestations that depend on where the lesions are located.

A

Chronic Complications

Diabetic Neuropathies

38
Q
  • a thickening of the walls of the blood vessels that supply nerves, causing a decrease in nutrients.
  • demyelinization of the Schwann cells that surround and insulate nerves, slowing nerve conduction.
  • Formation and accumulation of sorbitol with in the Schwann cells, impairing nerve conduction.
A

Etiology on Diabetic Neuropathy

39
Q

aka Somatic Neuropathies;

-Polyneuropathies and Mononeuropathies

A

Peripheral Neuropathies

40
Q

Most common type of neuropathy assoc. with diabetes. (bilateral sensory disorders)

  • 1st in the toes and feet, than progress upwards. Possible fingers and hands. Depends on which nerve fibers are involved.
  • Distal paresthesias
A

Polyneuropathies

41
Q

Isolated peripheral neuropathies that affect a single nerve. ie. Palsy of the 3rd cranial nerve (oculomotor)

A

Mononeuropathies

42
Q

Autonomic neuropathies cause various manifestations

  • Sweating dysfunction
  • Abnormal pupillary function
  • Cardiovascular dysfunction
  • Gastrointestinal dysfunction
  • Genitourinary dysfunction
  • Alterations in Mood
  • Increase Susceptibility to infection
  • Periodontal disease
  • Complications involving the feet.
A

Visceral Neuropathies

43
Q

Dx test; screening purposes, ongoing lab tests
-Hemoglobin A1C more than 6.5%
-Symptoms of diabetes plus casual plasma glucose more than 200 mg/dL
-Fasting plasma glucose more than 126 mg/dL
-2 hr PG more 200 mg/dL
Pre-diabetes; blood sugar between 100 to 126 mg/dL

A

Treatment

Dx testing for DM

44
Q

Blood Sugar between 100 to 126 mg/dL

A

Pre-diabetes

45
Q

-Fasting blood glucose (FBG); often ordered if client is experiencing symptoms of hypoglycemia or hyperglycemia. 70-110 mg/dL normal.

A

Diabetes Management Monitoring

46
Q

Avg. blood glucose level over 2-3 months.
_Glucose erratic/out of control, it attaches to the hemoglobin molecule and remains attached for the life of the hemoglobin. Avg. 120 days 7-9% elevated

A

Hemoglobin A1C

Dx test DM

47
Q

not as accurate in monitoring changes in blood glucose levels.
-presence of glucose in urine indicates hyperglycemia.
180 mg/dL; exceeds glucose not reabsorbed; spilled out into the urine.

A

Urine glucose & Ketone Levels

Dx urine test DM

48
Q

the presence of ketones in the urine. Occurs with the breakdown of fats; indicator of DKA.

A

Ketonuria

Dx urine test DM

49
Q

Urine test for the presence of protein as albumin (albumin-uria); 24 hr urine test for Creatinine clearance is used to detect early onset of nephropathy

A

Creatinine

Dx urine test DM

50
Q

indicate atherosclerosis and an increased risk of cardiovascular impairment.

A

Serum cholesterol and triglyceride levels

Dx test DM

51
Q

levels measured in clients who have DKA or hyperglycemic hyperosmolaric state (HHS) to determine imbalances.

A

Serum electrolytes

Dx test for DM

52
Q

Monitor Blood glucose

Urine testing for ketones and glucose

A

Dx testing for DM

53
Q

increased levels usually test falsely low in blood glucose, and clients with decreased usually test falsely higher.
-Anemia and sickle cell anemia affect hematocrit

A

Hematocrit levels DM

54
Q

Insulin; DM 1 must have insulin
DM 2 usually able to control glucose levels with an oral hypoglycemic medication, may require insulin.
-Controls hyperglycemia.
-Regular insulin is unmodified crystalline classified as a short-acting insulin. Only insulin given in an IV.

-Regular insulin used to treat DKA!
-NPH prolong their action, classified as intermediate; or long acting insulin.
-Insulin glargine (Lantus) 24 hr, long acting & DNA human insulin analog SubQ 1 or 2 days both for Type 1 and Type 2
[Levemir (detemir) and Glargine (Lantus)] is clear.

A

Pharmacology DM

Insulin

55
Q
Rapid acting; 
-lispro (Humalog)
-aspart (Novolog)
-glulisine (Apidra)
[all clear]
Frog on a Log; rapid tongue to get fly Novolog, Humalog
A

Pharmacology DM

Rapid acting Insulin

56
Q

Short acting:

Regular (Novolin R)

A

Pharmacology DM

Short acting Insulin

57
Q

Intermediate acting:
-NPH (Novolin R)
-Humulin N
cloudy

A

Pharmacology DM

Intermediate acting Insulin

58
Q

Long acting:
glargine (Lantus)
detemir (Levemir)

A

Pharmacology DM

Long acting Insulin

59
Q
Combos: 
Humalog 50/50
Humalog 75/25
Novolog 70/30
Humulin 70/30
Novolin 70/30
A

Pharmacology DM

Combo Insulin

60
Q

treat ind. with type 2 lower blood sugar by stimulating or increasing insulin secretion, preventing breakdown of glycogen to glucose by the liver and increase peripheral uptake of glucose by making cells less resistant to insulin.

  • Byetta (exenatide)
  • Victoza (liraglutide) GLP-1 agonists SubQ
  • Januvia (sitagliptin)
  • Tradjenta (linagliptin) DPP1V inhibitors
A

Pharmacology DM

Hypoglycemic Agents

61
Q

Diabetes ind. 4x more likely to die from CVD
-recommended dose of aspirin 81-325 mg reduce atherosclerosis in clients with vascular disease or increase cardiovascular risk factors.

A

Pharmacology DM

Aspirin therapy

62
Q

Careful balance between intake of nutrients, the expenditure of energy and the dose and timing of insulin or oral antidiabetic agents.

A

Nutrition DM

63
Q
  • Maintain a near normal blood glucose levels as possible balancing food intake with insulin or oral glucose.
  • Achieve optimal serum lipid levels.
  • Provide adequate calories to maintain or attain reasonable weights, and to recover from catabolic illness.
  • Prevent & treat the acute complications of insulin-treated DM, short-term illness and exercise- related problems, or the long-term complications of diabetes.
A

Nutritional implications for managing DM

64
Q

Sensible diet choices

  • Follow exercise plan
  • relate strategies that deal with hunger and making unhealthy food choices
  • support group
  • demonstrate regular weigh in appointments
A

Planning Nutrition DM

Exercise, Diet and Behavior modification

65
Q
  • identify food excess intake
  • realistic weight loss goals
  • 1 to 2 lbs/wk
  • knowledge of well balanced diet
  • Discuss behavior modification strategies
  • Monitor weight loss, bp and labs, including blood glucose and lipid levels
  • Encourage Exercise
  • Promote Weight loss
  • Promote Self-esteem
A

Implementation: Nutrition Obesity

Focus on Diet, exercise and Behavior Modifications

66
Q

-Carb Intake 45-60% daily diet
4kcal/g 130g/day
Plant foods, grains, fruits, vegs, milk and dairy products
*simple sugars and complex sugars

  • Protein 15-20% 4kcal/g low fat, low saturated fat, low cholesterol; prevent or delay renal complications
  • Sat fats; animal meats (meat, butter, fats, lard, bacon) cocoa butter, coconut oil, palm oil, and hydrogenated oils.
  • Polyunsaturated fat; oils of corn, safflower, sunflower, soybean, sesame seed & cottonseed

-Monosatured fats; peanut oil, olive oil and canola oil.
limit fat and cholesterol

-Fiber 20%/ day 35g/day

-Limit Na; 1, 000 mg ideal. Do not exceed 3,000mg/day;
2,300 mg recommended

A

Improve overall health through optimal nutrition, using MyPlate and Dietary Guidelines for Americans

67
Q

Health Promotion activities primarily focus on Preventing the complications of diabetes.

  • prevent or decrease excess weigh
  • follow a sensible and well balanced diet
  • maintain a regular physical exercise program
  • combo with meds and self monitoring
A

Nursing Process in management of patients with DM & Obesity (5)

68
Q

Family hx, HTN, cardiovas prob. hx of dizziness, numbness, esp. in hands and feet, pain when walking
-freq need to void, change in weight, appetite, infections and healing, problem with GI or urination, sexual function.

A

Assessment Health hx

(5) Nursing Process for DM & Obesity

69
Q

H&W ratio, VS, visual acuity, cranial nerves, sensory abilities in extremities (hot/cold), peripheral pulses, and skin & mucous membranes (hairloss, appearance) lesions, rash, itching, and vaginal discharge.

A

Physical assessment

Nursing Process for DM & Obesity 5

70
Q
  • Knowledge deficit
  • Risk for Impaired Skin Infection
  • Risk for Infection
  • Risk for Injury
  • Risk for Deficient Fluid Vol
  • Sexual Dysfunction
  • Ineffective Coping
A

Diagnosis DM & Obesity

Nursing Process 5

71
Q

Provide self care and reduce risk of complications.

  • describe how to administer meds and respond to side effects.
  • demonstrate meal planning
  • proper foot care and inspection
  • proper procedure for monitoring blood sugar.
  • describe strategies for reducing risk of infection.
A

Planning DM & Obesity

Nursing Process 5

72
Q

Teaches about the disease and management, planning dietary intake, providing emotional support, and creating strategies for daily management.
@ home teaching;
-information about normal metabolism, diabetes and how diabetes can change metabolism.
@ home diabetes care:
-how diet keeps blood glucose in normal range. # of kilocalories required and why?, amount of carbs, meats and fats allowed, and why?, how to calculate the diet while integrating personal food preferences.
-how to exercise to lower blood glucose, importance of a reg exercise program, types of exercise, integrating personal exercise preferences, and how to handle activity.
-Self monitoring of Blood Glucose; how to use equipment and what to do about high &/or low blood glucose.

A

Implementation; for DM & Obesity

Nursing Process 5

73
Q

Insulin: intravenous agents:
Type, dosage, mixing instructions, time of onset and peak actions, Get and care for equipment. How and where to give injections
-Manifestations; (acute complications) of hypoglycemia and hyperglycemia
What to do if they occur.
-hygiene, ie skin care, foot care, dental care
-what to do on a sick day
-helpful resources.

A

Medications;

Nursing Process DM & Obesity

74
Q

Changes in diet may be difficult.

  • changing bad habits.
  • maynot be eating balanced meals ever
  • purchasing, storing and preparing foods may be a problem
  • dentures might not fit well.
  • Changes in taste buds, increase salt and sugar intake.

-Need to exercise, may not be apart of life implement an exercise plan
-Dx of chronic illness threatens indep. and self worth (often leads to withdrawal)
-$ to purchase medications and supplies often taken out of fixed income.
-Visual deficits may make insulin diff. to admin.
Can interfere with monitoring, food prep, exercises and foot care.

A

Older people considerations DM & Obesity

75
Q

@ increased risk for decreased tissue perfusion, infection, and decreased or absent sensations from neuropathies.

  • teach foot care/hygiene
  • smoking cessation
  • discuss importance of blood glucose r/t diet, meds and exercise.
  • **Hyperglycemia promotes growth of microbes.
  • conduct foot care teaching sessions.
A

Maintaining skin Integrity DM & Obesity

76
Q

_Ind. with diabetes have increase risk for infection.

  • Handwashing!!!
  • monitor manifestations of infection
  • Increase temp, swelling, discharge, etc.
  • Discuss import. of skin care
  • Dental health

-Teach women symptoms and prevention of yeast infections.

A

Promoting Healthy Behaviors DM & Obesity

77
Q

-Neuropathies; alter sensations, gait, and muscle control.
-cataracts or retinopathy (visual deficits)
-hyperglycemia can cause blurred vision.
Increase risk of accidents, burns, falls, and trauma

  • Safety in home (teaching) and community
  • Monitor for & teach about recognizing and seek care for manifestations of DKA in type 1 DM
  • Monitor for and teach to recognize and seek care for manifestations of HHS with type 2 DM
  • Monitor for & teach to recognize and treat the manifestation of hypoglycemia; decrease blood glucose, anxiety, HA, uncoordinated movements, sweating, rapid pulse, drowsiness and visual changes.
  • Reduce environmental hazards
  • Recommend client wear a bracelet or alert necklace, incase of accident.
A

Maintain Safety for client with DM

78
Q

Sexual dysfunction (50% men) usually due to perpheral neuropathy.
-Libido usually not affected.
Women have less problems.
-include sexual hx
Provide info on actual and potential physical effects of diabetes on sexual function.
-provide counseling

A

Maintaining Sexual Health DM

79
Q

-Assess psychosocial resources.
emotional, support, financial, life style, communication skills
-explore effects from diabetes
-teach constructive problem solving techniq.
-Provide info on support groups.

A

Promote Effective coping DM

80
Q

Demonstrate an age appropriate understanding if diabetes self-management through meds, diet, exercise and blood glucose self monitoring activities.

  • client skin integrity remains intact
  • remains free of infection
  • remains free of injury

Diabetes Mellitus (DM) is a disorder of metabolism that results in hyperglycemia due to a defect in insulin secretion, insulin action, or both.

A

Evaluation/Goals Diabetes

81
Q

Serious physiological and psychological consequences and is assoc with increase morbidity and mortality

A

Obesity

82
Q

an excess of adipose tissue is one of the most prevalent preventable health problems in the US

A

Obesity

83
Q

Upper body obesity; central obesity waist-to-hip-ratio; greater than 1 in men or 0.8 in women

  • tend to have more intra-abdominal fat increased levels of circulating free fatty acids.
  • *Assoc risk HTN, abdominal blood lipid levels, heart disease, stroke and elevated insulin levels.
A

Clinical Manifestations of Obesity

84
Q

Lower body obesity; (peripheral obesity)
waist-to-hip ratio; less than 0.8 and is most common in women. Risk for hyperinsulinemia, abnormal lipids and heart disease.

A

Clinical Manifestations Obesity

85
Q

exercise, diet, and behavior modification. Pharmacology recommended if all else fails

A

Treatment for Obesity

86
Q

bariatric surgery;
usually limited to clients obese more than 40 kg/m2 waist
unable to lose through diet and exercise or serious issues with metabolic syndrome, HTN, heart disease

A

Surgical Treatment for Obesity

87
Q

-Cardiovascular disease
-HTN
-Coronary heart disease (CHD)
-Heart Failure
60% of obesity have Metabolic Syndrome
-Increase in waist circum., HTN, increase blood triglycerides, and fasting blood glucose. decreased HDL Cholesterol (want higher than 40)
-Identified risk factor for atherosclerosis and CHD
-heart failure; Left ventricular muscle mass increase, ventricle dilates b/c blood volume and increased CO.
-Obesity assoc obstructive sleep apnea
***Increase risk of Insulin resistance and type 2 DM

A

Complications of Obesity

88
Q
  • Affects reproductive function in Men and Women
  • Increase risk for developing Gallstones
  • several types of cancer
  • increase in stress on joints, osteoarthritis
  • Cardiovascular
  • Respiratory
  • Gastrointestinal
  • Genitourinary
  • Musculoskeletal
  • Endocrine and reproductive
  • Other; depression, eating-binge disorder, post-op complications
A

Complications of Obesity cont.

89
Q
  • BMI
  • Anthropometry; h&w, bone size, skin folds
  • Underwater weighing (hydrodensitometry)
  • Bioelectrical impedance
  • Waist circumference
  • Thyroid profile
  • Serum glucose
  • Serum cholesterol
  • Lipid profile
  • Electrocardiography
A

Dx tests for Obesity

90
Q
  • OTC, prescription
  • Amphetamines (increase potential for abuse)
  • Non-amphetamines suppressants (ie. phentermine)
  • Short-term promote weight loss; acts directly on appetite control center in CNS.
  • amphetamines; increase alertness, nervousness, and insomnia, reduce fatigue, can interfere with sleep.
  • *Use caution with heart patients
A

Pharm Therapy for Obesity

91
Q

-Sibutramine (Meridia); appetite suppressant acts on CNS.
Increase metabolic rate, lower cholesterol and triglyceride levels, but increase pulse rate and bp (limit for HTN, CHD, or heart failure pt)

A

Pharm therapy for obesity